Alcon Pharmaceuticals Buying Israeli Glaucoma Treatment Developer Belkin Vision
Belkin Vision has developed an efficient, non-contact, and automated glaucoma laser therapy accessible to all ophthalmologists.
Stay updated with breaking news from Michael Belkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Belkin Vision has developed an efficient, non-contact, and automated glaucoma laser therapy accessible to all ophthalmologists.
The Swiss-American ophthalmology company will pay $60 million immediately and up to $335 million with milestone payments for the company, BioLight reports.
In the first hour, author and journalist Dr. Naomi Wolf discusses her soon-to-be-released new book and an “X” debate on vaccine shedding. In the second hour, si
Fans of the project say a new hotel with a parking garage is just what the neighborhood needs. The new garage will have 373 spaces, including spots for scooters.
News and opinion relevant to families raising children with autism into adulthood and beyond.